Quality of life and its association with direct medical costs for COPD in urban China

Health and Quality of Life Outcomes

Volumn 13, Issue 1, 2015, Pages

  Wu, Minmin ^a   Zhao, Qi ^a   Chen, Yue ^b   Fu, Chaowei ^a   Xu, Biao ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

A cross sectional study; Chronic obstructive pulmonary disease; Medical cost; Quality of life

Indexed keywords

AGE; AGED; ARTICLE; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GENDER; HEALTH CARE COST; HUMAN; MALE; QUALITY OF LIFE; URBAN AREA; VISUAL ANALOG SCALE; COST OF ILLNESS; ECONOMICS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SELF CARE; SICKNESS IMPACT PROFILE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BEIJING; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SELF CARE; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; URBAN POPULATION;

EID: 84929146769     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-015-0241-5     Document Type: Article

References (32)

1. WHO. The top 10 causes of death. Available: http://www.who.int/mediacentre/factsheets/fs310/en/index.html . Accessed April 11, 2015.
2. Decramer M, Sibille Y, Bush A, Carlsen K-H, Rabe KF, Clancye L, et al. The European Union conference on chronic respiratory disease: purpose and conclusions. Eur Respir J. 2011;37(4):738-42.
3. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of Chronic Obstructive Pulmonary Disease in China: A Large, Population-based Survey. Am J Respir Crit Care Med. 2007;176(8):753-60.
4. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235-45.
5. Haave E, Hyland ME, Skumlien S. The relation between measures of health status and quality of life in COPD. Chron Respir Dis. 2006;3:195-9.
6. Weinstein MC, Siegel JE, Gold MR, Kamlet MS. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253-8.
7. Ramli A, Leonard J, Harun R. Preliminary evidence on the Feldenkrais Method as an alternative therapy for patients with chronic obstructive pulmonary disease. Focus on Alternative & Complementary Therapies an Evidence-Based Approach. 2013;18(3):126-32.
8. Blankenburg T, Guettel A, Busch C, Schuette W. Six-minute walk distance and dyspnoea scores to assess the course of COPD exacerbation in elderly patients. Clinical Respiratory Journal. 2013;7(3):261-7.
9. Shino Michael Y, Lynch JP, Saggar R, Abtin F, Belperio JA, Saggar R. Pulmonary Hypertension Complicating Interstitial Lung Disease and COPD. Seminars in Respiratory & Critical Care Medicine. 2013;34(5):600-19.
10. Yorgancioglu A, Havlucu Y, Celik P, Dinc G, Saka A. Relation between quality of life and morbidity and mortality in COPD patients: Two-year follow-up study. COPD. 2010;7(4):248-53.
11. Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary diseasepatients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757-64.
12. Punekar YS, Shukla A, Müllerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65-73.
13. Thayer RE, Newman JR, McClain TM. Self-regulation of mood: strategies for changing a bad mood, raising energy, and reducing tension. J Pers Soc Psychol. 1994;67(5):910-25.
14. Lemmens KM, Nieboer AP, Huijsman R. Designing patient related interventions in COPD care: empirical test of a theoretical model. Patient Educ Couns. 2008;72:223-31.
15. Ninot G, Moullec G, Picot MC, Jaussent A, Hayot M, Desplan M, et al. Cost-saving effect of supervised exercise associated to COPD self-management education program. Respir Med. 2011;105:377-85.
16. Collaboration P-T. Optimizing chronic disease management mega-analysis: economic evaluation. Ont Health Technol Assess Ser. 2013;13:1-148.
17. Susan G, Kathleen M. Fox and for the SHIELD Study Group: Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study. Health and Qulity of Life Outcoms. 2012;10:99-106.
18. COPD Group of Chinese Thoracic Society. The guideline for the diagnosis and treatment of COPD (updated in 2007). Ji Xu Yi Xue Jiao Yu, 2009;21(2):21-42.
19. Macran S, Weatherly H, Kind P. Measuring population health: a comparison of three generic health status measures. Med Care. 2003;41:218-31.
20. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
21. Global Strategy for Diagnosis, Management, and Prevention of COPD. Available: http://www.goldcopd.com/guidelines-global-strategy-for-diagnosis-management.html . Accessed April 11, 2015.
22. Suchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11(4):341-53.
23. Pickard AS, Wilke CT, Lin HW, Lloyd A. Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics. 2007;25(5):365-84.
24. Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43(7):736-49.
25. Osman LM, Ayres JG, Garden C, Reglitz K, Lyon J, Douglas JG. Home warmth and health status of COPD patients. Eur J Public Health. 2008;18(4):399-405.
26. Ståhl E1, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3:56.
27. Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9:26.
28. Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117-28.
29. Kim SH, Oh YM, Jo MW. Health-related quality of life in chronic obstructive pulmonary disease patients in Korea. Health Qual Life Outcomes. 2014;12:57.
30. Stavem K. Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res. 1999;8(1-2):45-54.
31. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care. 2000;38(6):583-637.
32. Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008;102(4):519-36.